What is the current stock price of Delta-Fly Pharma, Inc. (4598.T)?

As of the latest market data, Delta-Fly Pharma, Inc. (4598.T) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Delta-Fly Pharma, Inc. (4598.T) pay a dividend?

Based on current data, Delta-Fly Pharma, Inc. does not have a confirmed active dividend policy.

What is the market cap of Delta-Fly Pharma, Inc.?

The current market capitalization of Delta-Fly Pharma, Inc. (4598.T) is approximately unavailable.

4598.T

Delta-Fly Pharma, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 that is in phase III clinical trial in the United States and phase I trial in Japan for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323, which is in phase III clinical trial to treat lung cancer; DFP-17729 that is in phase I/II clinical trials for the treatment of solid cancer; DFP-11207, which has completed phase I clinical trial to treat pancreatic cancer; DFP-14927 that is in phase I for the treatment of hematologic cancer; and DFP-10825, which is in preclinical trial to treat gastric/ovarian cancer. Delta-Fly Pharma, Inc. was incorporated in 2010 and is headquartered in Tokushima, Japan.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2018-10-12

Beta

-0.73

Websitewww.delta-flypharma.co.jp↗